These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 18776472)

  • 1. Suppression of bcr-abl mRNA by chemically modified siRNA.
    Murao S; Diala I; Fujii M
    Nucleic Acids Symp Ser (Oxf); 2008; (52):499-500. PubMed ID: 18776472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficient silencing of bcr/abl oncogene by single- and double-stranded siRNAs targeted against b2a2 transcripts.
    Rapozzi V; Xodo LE
    Biochemistry; 2004 Dec; 43(51):16134-41. PubMed ID: 15610007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of bcr-abl and/or c-abl gene expression by small interfering, double-stranded RNAs: cross-talk with cell proliferation factors and other oncogenes.
    Ohba H; Zhelev Z; Bakalova R; Ewis A; Omori T; Ishikawa M; Shinohara Y; Baba Y
    Cancer; 2004 Sep; 101(6):1390-403. PubMed ID: 15368327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of bcr-abl synthesis by siRNAs or tyrosine kinase activity by Glivec alters different oncogenes, apoptotic/antiapoptotic genes and cell proliferation factors (microarray study).
    Zhelev Z; Bakalova R; Ohba H; Ewis A; Ishikawa M; Shinohara Y; Baba Y
    FEBS Lett; 2004 Jul; 570(1-3):195-204. PubMed ID: 15251464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of siRNAs in combination with Gleevec on K-562 cell proliferation and Bcr-Abl expression.
    Baker BE; Kestler DP; Ichiki AT
    J Biomed Sci; 2006 Jul; 13(4):499-507. PubMed ID: 16547768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of specific siRNA targeting against bcr-abl chimeric gene on chronic myelogenous leukemia cells].
    Wang S; Chai YB; Liu F; Zhang XY; Jia W; Xie X; Yu WQ; Shang ZC; Jin BQ; Sun BZ
    Zhonghua Yi Xue Za Zhi; 2005 Jan; 85(3):198-202. PubMed ID: 15854468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delivery of therapeutic shRNA and siRNA by Tat fusion peptide targeting BCR-ABL fusion gene in Chronic Myeloid Leukemia cells.
    Arthanari Y; Pluen A; Rajendran R; Aojula H; Demonacos C
    J Control Release; 2010 Aug; 145(3):272-80. PubMed ID: 20403398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RNA interference targeting of Bcr-Abl increases chronic myeloid leukemia cell killing by 17-allylamino-17-demethoxygeldanamycin.
    Withey JM; Harvey AJ; Crompton MR
    Leuk Res; 2006 May; 30(5):553-60. PubMed ID: 16260034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Inhibitory effect of RNA interference on chronic myeloid leukemia bcr/abl oncogene expression].
    Ma XX; Wang C; Wei J; Qin YW; Yan SK; Gao YR; Cai Q
    Zhonghua Xue Ye Xue Za Zhi; 2005 Jun; 26(6):359-62. PubMed ID: 16185484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Construction of eukaryotic expression vector of siRNA specific to bcr/abl fusion gene].
    Xi YM; Liu T; Meng WT; Wang YH; Gu L; Lu XX; Gong YP
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 Jul; 36(4):460-3. PubMed ID: 16078560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transferrin receptor-targeted liposomes encapsulating anti-BCR-ABL siRNA or asODN for chronic myeloid leukemia treatment.
    Mendonça LS; Firmino F; Moreira JN; Pedroso de Lima MC; Simões S
    Bioconjug Chem; 2010 Jan; 21(1):157-68. PubMed ID: 20000596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting primary human leukaemia cells with RNA interference: Bcr-Abl targeting inhibits myeloid progenitor self-renewal in chronic myeloid leukaemia cells.
    Withey JM; Marley SB; Kaeda J; Harvey AJ; Crompton MR; Gordon MY
    Br J Haematol; 2005 May; 129(3):377-80. PubMed ID: 15842662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene therapy for BCR-ABL+ human CML with dual phosphorylation resistant p27Kip1 and stable RNA interference using an EBV vector.
    Sengupta A; Banerjee D; Chandra S; Banerjee S
    J Gene Med; 2006 Oct; 8(10):1251-61. PubMed ID: 16952195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extremely high and specific activity of DNA enzymes in cells with a Philadelphia chromosome.
    Warashina M; Kuwabara T; Nakamatsu Y; Taira K
    Chem Biol; 1999 Apr; 6(4):237-50. PubMed ID: 10099134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on aminoisonucleoside modified siRNAs: stability and silencing activity.
    Li ZS; Qiao RP; Du Q; Yang ZJ; Zhang LR; Zhang PZ; Liang ZC; Zhang LH
    Bioconjug Chem; 2007; 18(4):1017-24. PubMed ID: 17539595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. WT1 and BCR-ABL specific small interfering RNA have additive effects in the induction of apoptosis in leukemic cells.
    Elmaagacli AH; Koldehoff M; Peceny R; Klein-Hitpass L; Ottinger H; Beelen DW; Opalka B
    Haematologica; 2005 Mar; 90(3):326-34. PubMed ID: 15749664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nuclear topography and expression of the BCR/ABL fusion gene and its protein level influenced by cell differentiation and RNA interference.
    Bártová E; Harnicarová A; Pacherník J; Kozubek S
    Leuk Res; 2005 Aug; 29(8):901-13. PubMed ID: 15978941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Silencing of BCR/ABL Chimeric Gene in Human Chronic Myelogenous Leukemia Cell Line K562 by siRNA-Nuclear Export Signal Peptide Conjugates.
    Shinkai Y; Kashihara S; Minematsu G; Fujii H; Naemura M; Kotake Y; Morita Y; Ohnuki K; Fokina AA; Stetsenko DA; Filichev VV; Fujii M
    Nucleic Acid Ther; 2017 Jun; 27(3):168-175. PubMed ID: 28355131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of modified siRNA bearing C-5 polyamine-substituted pyrimidine nucleoside in their 3'-overhang regions and its RNAi activity.
    Masud MM; Masuda T; Inoue Y; Kuwahara M; Sawai H; Ozaki H
    Bioorg Med Chem Lett; 2011 Jan; 21(2):715-7. PubMed ID: 21190853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and properties of modified siRNA having amide-linked oligoribonucleosides at their 3' overhang regions.
    Iwase R; Miyao H; Toyama T; Nishimori K
    Nucleic Acids Symp Ser (Oxf); 2006; (50):175-6. PubMed ID: 17150874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.